Esopam 10 Adverse Reactions

Adverse reactions are most frequent during the first or second week of treatment and usually decrease in intensity and frequency with continued treatment.
Tabulated list of adverse reactions: Adverse reactions known for Escitalopram are listed below by system organ class and frequency: (See table.)

Click on icon to see table/diagram/image

QT interval prolongation: Cases of QT interval prolongation and ventricular arrhythmia including Torsade de pointes can be observed predominantly in patients of female gender with hypokalemia or with pre-existing QT interval prolongation or other cardiac diseases (see Contraindications, Warnings, Precautions, Interactions, Overdose and Pharmacology under Actions).
Class effects: Increased risk of bone fractures can be observed in patients receiving SSRIs and TCAs. The mechanism leading to this risk is unknown.
Discontinuation symptoms seen when stopping treatment: Discontinuation of SSRIs/SNRIs (particularly when abrupt) commonly leads to discontinuation symptoms. Dizziness, sensory disturbances (including paraesthesia and electric shock sensations), sleep disturbances (including insomnia and intense dreams), agitation or anxiety, nausea and/or vomiting, tremor, confusion, sweating, headache, diarrhea, palpitations, emotional instability, irritability, and visual disturbances are the most common reactions. Generally these events are mild to moderate and are self-limiting; however, in some patients they may be severe and/or prolonged. It is therefore advised that when Escitalopram treatment is no longer required, gradual discontinuation by dose tapering should be carried out (see Dosage & Administration, Warnings and Precautions).